Two advisers to U.S. Health and Human Services Secretary Robert F. Kennedy Jr. sat on a stage in California this spring, ...
Discover how potential U.S. price cuts on obesity drugs could impact LLY and NVO revenues, stock sentiment, and valuation ...
Bristol-Myers Squibb Company has had a recent 30% stock decline amid concerns over patent expirations. Click here to read why BMY stock is a Hold.
PayNearby CEO announces plans for an IPO in 2-3 years, highlighting growth, new products, and a strong retail network.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback